A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis
NCT ID: NCT06007300
Last Updated: 2023-08-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
300 participants
OBSERVATIONAL
2023-08-31
2026-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective Multi-omics Observational Study of Gynecological Rare Pathological Tumors
NCT05985941
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA Fragmentomics
NCT06083779
A Study to Analyze Data on Metastatic Ovarian Cancer Using Multi-omics
NCT05251883
Biomarkers in Tissue Samples From Patients With Stage I or Stage III Endometrial Cancer
NCT01119573
Translational Study of MSS, TP53 Mutation and Chromosome Instability Relationship in Endometrial Carcinoma
NCT06521684
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Normal Group
Patients with normal endometrium
No interventions assigned to this group
Precancerous Group
Patients with atypical hyperplasia of endometrium
No interventions assigned to this group
Carcinoma Group
Patients with endometrial cancer
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Obtain pathological results after undergoing hysteroscopic surgery or hysterectomy;
* The patient voluntarily participated in this research project with good compliance and was able to complete the enrollment according to the experimental requirements;
* Sign the informed consent form and consent to the collection and use of their data, and consent to genomics, transcriptome and other tests.
Exclusion Criteria
* Suffering from uncontrollable neurological diseases, psychiatric diseases, or psychiatric disorders;
* Poor compliance and inability to cooperate and describe treatment responders.
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
RenJi Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LY-2023-136-B
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.